Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J’s Clinical Data Disclosure Strategy Focuses On Collaboration With Yale University Group

This article was originally published in The Pink Sheet Daily

Executive Summary

In what appears to be the most expansive policy to date on release of clinical trial data, J&J will use an existing outside group and will share full clinical study reports and patient-level data regardless of when the studies were conducted.

Advertisement

Related Content

Clinical Trial Data Sharing: Central Public-Private Portal May Expand Access
BIO 2015 Dispatches: Data Transparency Initiatives Could Deter Industry Investment, Attorney Says
Clinical Trial Transparency Gets A Boost With J&J Agreement, IOM Report
Clinical Data Disclosure Embraced By Pharma; Now It Needs Partners
Failed Pediatric Study Data To Get FDA Review At Patient Meeting
Clinical Data Transparency Would Counter-Balance Off-Label Promotion – NEJM
BIO’s Clinical Trial Disclosure Policy Allows Researchers Access To Data On Approved Medicines
JAMA Studies Provide More Ammunition For Trial Disclosure Reformers
Clinical Trials Transparency: EMA Delay Gives Industry Initiative More Time To Take Root
No Advantage For Medtronic’s InFuse Versus Bone Graft In Spine Fusion

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS076456

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel